MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CHUANG, D.-M.
Right arrow Articles by COSTA, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CHUANG, D.-M.
Right arrow Articles by COSTA, E.

Molecular Pharmacology, Vol 18, 348-355, Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics

A Biochemical Study of Receptor Internalization during beta-Adrenergic Receptor Desensitization in Frog Erythrocytes

DE-MAW CHUANG 1, WILLIAM J. KINNIER 1, LEN FARBER 1, and ERMINIO COSTA 1

1 Laboratory of Preclinical Pharmacology, National Institute of Mental Health, Saint Elizabeths Hospital, Washington, D. C. 20032

We have previously reported that in frog erythrocytes, a decrease in the number of beta-adrenergic receptor recognition sites during subsensitivity of these receptors is associated with a translocation to the cytosol of beta-adrenergic receptor recognition sites located on the red cell membrane. These results suggest that the recognition sites of beta-adrenergic receptors located in the plasma membrane internalize following a persistent receptor stimulation. Experiments using cells incubated with (±)-[3H]hydroxybenzylisoproterenol (HBI), a potent beta-agonist, suggest that the agonist is bound to the internalized recognition sites of beta-adrenergic receptors. The increase in the number of receptors found in cytosol and the decrease of those found in the particulate fraction were inhibited by lowering the preincubation temperature. The binding capacity of these internalized sites was blocked by Pronase but was resistant to phospholipase treatment. Dinitrophenol and cordycepin inhibited the agonist-elicited internalization of beta-adrenergic receptors, suggesting an ATP-requiring metabolic process (protein phosphorylation?) may participate in causing this event. Preincubation of cells with doses of concanavalin A which induce erythrocyte agglutination was found to inhibit the internalization of the receptors induced by the agonist. Pretreatment with methylamine in millimolar ranges also reduced the extent of beta-receptor internalization. These results strongly suggest that the internalization of beta-adrenergic receptor recognition sites may be triggered by receptor clustering mediated by transglutaminase. The catalytic subunits of adenylate cyclase were not found to be internalized under conditions in which we found maximal internalization of beta-adrenergic receptor recognition sites. Although guanyl-5'-yl imidodiphosphate (Gpp(NH)p) and GTP affected the binding of (-)-isoproterenol to beta-adrenergic receptors in the particulate fraction, these guanine nucleotides failed to modify agonist binding to recognition sites of soluble internalized beta-receptors.

Submitted on February 4, 1980
Accepted on June 23, 1980







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics